Overall, this suggests no major disruption of signalling by ATR and ATM in Eμ-Myc Rel−/− lymphomas but that specific targets exhibit changes in phosphorylation that could impact on the phenotype of these cells. The gene discussed is ATR; the disease is lymphoma.